Figures & data
Figure 1 Isolation process and potential therapeutic products derived from lipoaspirate.
![Figure 1 Isolation process and potential therapeutic products derived from lipoaspirate.](/cms/asset/63fff4d8-62f7-45ed-8e5d-48e6eee743a7/dscc_a_64373_f0001_c.jpg)
Figure 2 Fluorescence-activated cell sorting characterization of (A) nonhematopoietic (CD45-) cells of stromal vascular fraction (SVF) and (B) adherent purified adipose-derived stem cells (ASC). (C) Summary of flow cytometry cell surface marker expression analysis for uncultured endothelial progenitor cells (EPC) in SVF, uncultured ASC in SVF, and adherent purified ASC.
![Figure 2 Fluorescence-activated cell sorting characterization of (A) nonhematopoietic (CD45-) cells of stromal vascular fraction (SVF) and (B) adherent purified adipose-derived stem cells (ASC). (C) Summary of flow cytometry cell surface marker expression analysis for uncultured endothelial progenitor cells (EPC) in SVF, uncultured ASC in SVF, and adherent purified ASC.](/cms/asset/88f3d8b1-1f06-47a7-b9a9-3de2ba09bc0c/dscc_a_64373_f0002_c.jpg)
Figure 4 Clinical trials registered on http://www.ClinicalTrials.gov focused on adipose stem or stromal cells as at April 2015.
![Figure 4 Clinical trials registered on http://www.ClinicalTrials.gov focused on adipose stem or stromal cells as at April 2015.](/cms/asset/8cc84f29-a000-4ef0-b1d8-ae2acfb7b01d/dscc_a_64373_f0004_b.jpg)